Brought to you by 
Xenova bought out by Celtic Pharma
17 Feb 2023
Executive Summary
Xenova PLC (therapeutics for cancer and addiction; focuses on immunotherapy) has agreed to be acquired by Celtic Pharma, a newly formed private equity investment fund targeting the pharma industry, for £26.1mm ($47.5mm).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Payment Includes Cash for Equity
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Xenova bought out by Celtic Pharma
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice